AJP - Endo Cosmo Bio: Excellent Endocrine ELISAs
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 251: E104-E110, 1986;
0193-1849/86 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoelzer, D. R.
Right arrow Articles by Cryer, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoelzer, D. R.
Right arrow Articles by Cryer, P. E.

AJP - Endocrinology and Metabolism, Vol 251, Issue 1 104-E110, Copyright © 1986 by American Physiological Society

ARTICLES

Epinephrine is not critical to prevention of hypoglycemia during exercise in humans

D. R. Hoelzer, G. P. Dalsky, N. S. Schwartz, W. E. Clutter, S. D. Shah, J. O. Holloszy and P. E. Cryer

We documented stability of plasma glucose concentrations and glucose production and utilization rates, and levels of other metabolic substrates and regulatory factors, during the islet clamp (somatostatin infusion with glucagon and insulin replacement) in the absence of an intervention in five normal humans and further applied this technique to the study of glucoregulation during moderate exercise. Based on previous evidence that sympathochromaffin activation plays a primary role in the prevention of hypoglycemia during exercise, the role of adrenomedullary catecholamines was assessed by exercise (60% of maximum oxygen consumption for 60 min) studies in four bilaterally adrenalectomized, epinephrine-deficient humans under two conditions: control (saline infusion) and islet clamp. Increased glucose utilization and production rates were matched and plasma glucose was unchanged during exercise under both conditions. Thus adrenomedullary catecholamines including epinephrine are not critical to glucoregulation during moderate exercise in humans even when changes in insulin and glucagon are prevented. These findings provide further support for the suggestion that sympathetic neural norepinephrine is the operative catecholamine in the prevention of hypoglycemia during exercise in humans.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, Y. Koyama, D. B. Lacy, P. E. Williams, N. Rheaume, and D. H. Wasserman
Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1122 - E1129.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Howlett, M. Febbraio, and M. Hargreaves
Glucose production during strenuous exercise in humans: role of epinephrine
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1130 - E1135.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. Del Corral, E. T. Howley, M. Hartsell, M. Ashraf, and M. S. Younger
Metabolic effects of low cortisol during exercise in humans
J Appl Physiol, March 1, 1998; 84(3): 939 - 947.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. H. Coker, M. G. Krishna, D. B. Lacy, E. J. Allen, and D. H. Wasserman
Sympathetic drive to liver and nonhepatic splanchnic tissue during heavy exercise
J Appl Physiol, April 1, 1997; 82(4): 1244 - 1249.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online